Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

BACKGROUND AND PURPOSE: Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Stroke
Hauptverfasser: Lee, Eun-Jae, Kwon, Sun U., Park, Jong-Ho, Kim, Yong-Jae, Hong, Keun-Sik, Yu, Sungwook, Hwang, Yang-Ha, Lee, Ji Sung, Lee, Juneyoung, Rha, Joung-Ho, Heo, Sung Hyuk, Ahn, Sung Hwan, Seo, Woo-Keun, Park, Jong-Moo, Lee, Ju-Hun, Kwon, Jee-Hyun, Sohn, Sung-Il, Jung, Jin-Man, Kim, Hahn Young, Kim, Eung-Gyu, Kim, Sung Hun, Cha, Jae-Kwan, Park, Man-Seok, Nam, Hyo Suk, Kang, Dong-Wha
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Stroke Society 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7005357/
https://ncbi.nlm.nih.gov/pubmed/32027796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5853/jos.2019.02551
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge